Skip to main content
. 2018 May;10(Suppl 13):S1438–S1446. doi: 10.21037/jtd.2018.05.130

Figure 2.

Figure 2

A 42-year-old female patient with NSCLC in treatment with nivolumab (anti-PD-1 monoclonal antibody). Axial chest CT reveals interlobular septal thickening with small patchy ground-glass opacities in the lower lobes, in a crazy-paving configuration. NSCLC, non-small cell lung cancer.